Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cabaletta Bio ( (CABA)) has shared an ...

MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced the publication of a peer-reviewed article in Biomolecules detailing the pharmacokinetic profile of a newly developed crystal form of buntanetap, ...

New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody CLYM116 Phase 1 trial initiation expected in Q4 2025, with ...

News of an easing of U.S.-China trade tensions has not only added another leg up for the stock market but it's finally notably impacted an important indicator of market angst. The Cboe Volatility ...

Caught between the rock and the hard place of most-favored nation (MFN) pricing and the threat of a hefty biopharma sector tariff, drug companies marketing in the U.S. are exploring their options.

U.S.-based Barinthus Biotherapeutics is entering a reverse merger with U.K. biotech Clywedog Therapeutics, with the combined company expected to advance three clinical assets across diabetes and ...

Prime Minister Benjamin Netanyahu’s flight to the US took a circuitous route in an apparent effort to avoid countries that could enforce an outstanding arrest warrant against him for alleged war ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

*Tesla and IBM have taken a lower turn following their earnings reports. *Oil prices have moved higher in the wake of sanctions for Rosneft and Lukoil. *Mega-cap stocks continue to trade in a timid ...

New students should review and/or take action on the following: Please complete the Advisement and Orientation Form within 1 week of submitting your tuition deposit. For most students, the Advisement ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...